News and Trends 8 Nov 2022
Collaboration to develop CAR-T cell therapy for cutaneous T-cell lymphoma
The Peter MacCallum Cancer Centre (Peter Mac) and Cartherics Pty Ltd (Cartherics) have entered into a collaborative development program agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001)…